Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis a cohort study

American Journal of Respiratory and Critical Care Medicine

Volumn 195, Issue 2, 2017, Pages 205-211

  Klein Klouwenberg, Peter M C ^a   Frencken, Jos F ^a   Kuipers, Sanne ^a   Ong, David S Y ^a   Peelen, Linda M ^a   Van Vught, Lonneke A ^b   Schultz, Marcus J ^b   Van Der Poll, Tom ^b   Bonten, Marc J ^a   Cremer, Olaf L ^a   De Beer, Friso M ^b   Bos, Lieuwe D J ^b   Glas, Gerie J ^b   Van Hooijdonk, Roosmarijn T M ^b   Hoogendijk, Arie J ^b   Huson, Mischa A ^b   Schouten, Laura R A ^b   Straat, Marleen ^b   Witteveen, Esther ^b   Wieske, Luuk ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Atrial fibrillation; Epidemiology; Intensive care unit; Mortality; Risk factors

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; MAGNESIUM; SOTALOL;

ADULT; AGED; ARTICLE; CALIBRATION; CARDIOVERSION; COHORT ANALYSIS; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MORTALITY RISK; NETHERLANDS; NEW-ONSET ATRIAL FIBRILLATION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SEPTIC SHOCK; TERTIARY CARE CENTER; ATRIAL FIBRILLATION; COMPLICATION; MIDDLE AGED; MORTALITY;

AGED; ATRIAL FIBRILLATION; COHORT STUDIES; CRITICAL ILLNESS; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; RISK FACTORS; SEPSIS;

EID: 85009773511     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201603-0618OC     Document Type: Article

References (31)

1. Annane D, Sébille V, Duboc D, Le Heuzey JY, Sadoul N, Bouvier E, Bellissant E. Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med 2008;178:20-25.
2. Artucio H, Pereira M. Cardiac arrhythmias in critically ill patients: epidemiologic study. Crit Care Med 1990;18:1383-1388.
3. Brathwaite D, Weissman C. The new onset of atrial arrhythmias following major noncardiothoracic surgery is associated with increased mortality. Chest 1998;114:462-468.
4. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840-851.
5. Seguin P, Launey Y. Atrial fibrillation is not just an artefact in the ICU. Crit Care 2010;14:182.
6. Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA 2011;306:2248-2254.
7. Meierhenrich R, Steinhilber E, Eggermann C, Weiss M, Voglic S, Bögelein D, Gauss A, Georgieff M, Stahl W. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care 2010;14:R108.
8. Kuipers S, Klein Klouwenberg PM, Cremer OL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care 2014;18:688.
9. Salman S, Bajwa A, Gajic O, Afessa B. Paroxysmal atrial fibrillation in critically ill patients with sepsis. J Intensive Care Med 2008;23:178-183.
10. Christian SA, Schorr C, Ferchau L, Jarbrink ME, Parrillo JE, Gerber DR. Clinical characteristics and outcomes of septic patients with newonset atrial fibrillation. J Crit Care 2008;23:532-536.
11. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 2013; 310:1683-1691.
12. Klein Klouwenberg PM, Ong DS, Bos LD, de Beer FM, van Hooijdonk RT, Huson MA, Straat M, van Vught LA, Wieske L, Horn J, et al. Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med 2013;41:2373-2378.
13. Wolkewitz M, Vonberg RP, Grundmann H, Beyersmann J, Gastmeier P, Bärwolff S, Geffers C, Behnke M, Rüden H, Schumacher M. Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care 2008;12:R44.
14. Walkey AJ, Greiner MA, Heckbert SR, Jensen PN, Piccini JP, Sinner MF, Curtis LH, Benjamin EJ. Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors. Am Heart J 2013;165:949-955, e3.
15. Gibbs HR, Swafford J, Nguyen HD, Ewer MS, Ali MK. Postoperative atrial fibrillation in cancer surgery: preoperative risks and clinical outcome. J Surg Oncol 1992;50:224-227.
16. Hidalgo JD, Krone R, Rich MW, Blum K, Adkins D, Fan MY, Brown R, Devine S, Graubert T, Blum W, et al. Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant 2004; 34:615-619.
17. Wells GL, Morris PE. Incidence and prognosis of atrial fibrillation in patients with sepsis. Card Res 2011;2:293-297.
18. Steyerberg EW. Clinical prediction models. New York: Springer-Verlag; 2009.
19. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108:3006-3010.
20. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997;30:1039-1045.
21. Cavaliere F, Volpe C, Soave M. Atrial fibrillation in intensive care units [abstract]. Curr Anaesth Crit Care 2006;17:367-374.
22. O'Neill PG, Puleo PR, Bolli R, Rokey R. Return of atrial mechanical function following electrical conversion of atrial dysrhythmias. Am Heart J 1990;120:353-359.
23. Tisdale JE, Wroblewski HA, Wall DS, Rieger KM, Hammoud ZT, Young JV, Kesler KA. A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. Ann Thorac Surg 2009; 88:886-893; discussion 894-885.
24. Tisdale JE, Wroblewski HA, Wall DS, Rieger KM, Hammoud ZT, Young JV, Kesler KA. A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy. J Thorac Cardiovasc Surg 2010;140:45-51.
25. Kerstein J, Soodan A, Qamar M, Majid M, Lichstein E, Hollander G, Shani J. Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. Chest 2004;126: 716-724.
26. Kinnear J, Higgins D, Stone A, Armstrong M. New-onset atrial fibrillation in the intensive care unit: a survey of current practice in the UK: 12AP8-2. Eur J Anaesthesiol 2007;24:159.
27. Sleeswijk ME, Van Noord T, Tulleken JE, Ligtenberg JJ, Girbes AR, Zijlstra JG. Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients: a clinical framework. Crit Care 2007; 11:233.
28. Martinez EA, Bass EB, Zimetbaum P; American College of Chest Physicians. Pharmacologic control of rhythm: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005;128 (Suppl. 2):48S-55S.
29. Aasbo JD, Lawrence AT, Krishnan K, Kim MH, Trohman RG. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann Intern Med 2005;143:327-336.
30. Arsenault KA, Yusuf AM, Crystal E, Healey JS, Morillo CA, Nair GM, Whitlock RP. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev 2013;1:CD003611.
31. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J 2006;27:2846-2857.